Fuster V - Search Results

1

Acute coronary syndromes: pathophysiology and preventive priorities.

Badimon JJ, Zaman A, Helft G, Fayad Z, Fuster V. Badimon JJ, et al. Among authors: fuster v. Thromb Haemost. 1999 Aug;82(2):997-1004. Thromb Haemost. 1999. PMID: 10605815 Review. No abstract available.

2

Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.

Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L. Badimon JJ, et al. Among authors: fuster v. Thromb Haemost. 1994 Apr;71(4):511-6. Thromb Haemost. 1994. PMID: 8052972

3

The three processes leading to post PTCA restenosis: dependence on the lesion substrate.

Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon JJ. Fuster V, et al. Thromb Haemost. 1995 Jul;74(1):552-9. Thromb Haemost. 1995. PMID: 8578523 Review. No abstract available.

4

The unstable atherosclerotic plaque: clinical significance and therapeutic intervention.

Fuster V, Fallon JT, Badimon JJ, Nemerson Y. Fuster V, et al. Thromb Haemost. 1997 Jul;78(1):247-55. Thromb Haemost. 1997. PMID: 9198161 Review. No abstract available.

5

Pathogenesis of thrombosis in coronary artery disease.

Chesebro JH, Rauch U, Fuster V, Badimon JJ. Chesebro JH, et al. Among authors: fuster v. Haemostasis. 1997;27 Suppl 1:12-8. doi: 10.1159/000217477. Haemostasis. 1997. PMID: 9439753 Review.

6

Acute coronary syndromes: biology.

Fuster V, Fayad ZA, Badimon JJ. Fuster V, et al. Lancet. 1999 Jun;353 Suppl 2:SII5-9. doi: 10.1016/s0140-6736(99)90234-9. Lancet. 1999. PMID: 10374759 Review. No abstract available.

7

Coronary artery disease: pathogenesis and acute coronary syndromes.

Worthley SG, Osende JI, Helft G, Badimon JJ, Fuster V. Worthley SG, et al. Among authors: fuster v. Mt Sinai J Med. 2001 May;68(3):167-81. Mt Sinai J Med. 2001. PMID: 11373689 Review.

8

Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes.

Fuster V, Corti R, Fayad ZA, Schwitter J, Badimon JJ. Fuster V, et al. J Thromb Haemost. 2003 Jul;1(7):1410-21. doi: 10.1046/j.1538-7836.2003.00271.x. J Thromb Haemost. 2003. PMID: 12871275 Free article. Review.

9

Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist.

Osende JI, Shimbo D, Fuster V, Dubar M, Badimon JJ. Osende JI, et al. Among authors: fuster v. J Thromb Haemost. 2004 Mar;2(3):492-8. doi: 10.1111/j.1538-7933.2004.00639.x. J Thromb Haemost. 2004. PMID: 15009468 Free article.

10

Normalization of platelet reactivity in clopidogrel-treated subjects.

Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ. Vilahur G, et al. Among authors: fuster v. J Thromb Haemost. 2007 Jan;5(1):82-90. doi: 10.1111/j.1538-7836.2006.02245.x. J Thromb Haemost. 2007. PMID: 17239165 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,587 results

Search Page

Filters